THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 81 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2016. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $617,425 | -16.7% | 71,620 | +0.0% | 0.00% | – |
| Q2 2023 | $740,970 | -52.4% | 71,604 | +66.5% | 0.00% | -100.0% |
| Q3 2016 | $1,558,000 | +59.6% | 43,018 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $976,000 | +19.5% | 43,018 | -1.1% | 0.00% | – |
| Q1 2016 | $817,000 | +14.6% | 43,492 | -0.1% | 0.00% | – |
| Q4 2015 | $713,000 | +176.4% | 43,522 | +85.1% | 0.00% | – |
| Q3 2015 | $258,000 | -19.4% | 23,518 | -4.4% | 0.00% | – |
| Q2 2015 | $320,000 | -36.6% | 24,606 | -15.4% | 0.00% | – |
| Q1 2015 | $505,000 | +16.4% | 29,078 | -0.1% | 0.00% | – |
| Q4 2014 | $434,000 | -35.3% | 29,105 | -0.1% | 0.00% | – |
| Q3 2014 | $671,000 | -27.8% | 29,120 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $929,000 | – | 29,120 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
| Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
| Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
| Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
| Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
| Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
| King Wealth Management Group | 22,500 | $583,000 | 0.15% |
| Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |